Sterling Addlife India Limited, Rajkot, India.
Thromb Res. 2012 Apr;129(4):e152-8. doi: 10.1016/j.thromres.2012.01.012. Epub 2012 Feb 11.
The VOICE Asia study aimed to establish the mode of thromboprophylaxis in medical patients admitted to intensive care units (ICU), and to describe the epidemiology of patients at high-risk of venous thromboembolism (VTE) and of patients who were prescribed low molecular weight heparin (LMWH).
This multinational, observational, cross-sectional study recruited medical patients admitted to ICU in whom a decision to give VTE prophylaxis had been taken. The treating physicians decided patient management. We recorded demographics, VTE risk factors, VTE risk assessment, thromboprophylaxis, and compliance to the American College of Chest Physicians (ACCP) guidelines.
The study enrolled 2969 patients from 113 centers in 5 Asian countries. The most common VTE risk factors were age > 60 years (57.1%), prolonged immobility (50.6%), respiratory diseases (41.3%), and acute infectious disease (36.2%). There was a wide gap between physicians' assessment of 'very high' risk for VTE (8.4%) and Caprini 'very high' risk stratification (54.9%). 2919 (98.3%) patients received prophylaxis (22.9%-only mechanical, 31.2%-only pharmacological, 44.2%-both, mechanical and pharmacological and 1.7%- no prophylaxis). Early mobilization (44.3%) and LMWH (66.2%, mean duration of prophylaxis-8.6 days) were the most common mechanical and pharmacological prophylaxis, respectively. 80.6% of patients were given thromboprophylaxis as per the ACCP guidelines (and 4.7% per Japanese guidelines).
There is substantial underestimation of VTE risk and non-adherence to guidelines for thromboprophylaxis in medical ICU patients in participating Asian countries. This emphasizes the need for increasing awareness about optimum VTE risk assessment and improved implementation of appropriate thromboprophylaxis in at-risk medical ICU patients.
亚洲 VOICE 研究旨在确定入住重症监护病房(ICU)的内科患者的血栓预防模式,并描述静脉血栓栓塞(VTE)高危患者和接受低分子肝素(LMWH)治疗患者的流行病学情况。
这项多中心、观察性、横断面研究纳入了已决定给予 VTE 预防治疗的 ICU 内科患者。主治医生决定患者的管理方案。我们记录了患者的人口统计学资料、VTE 风险因素、VTE 风险评估、血栓预防以及对美国胸科医师学会(ACCP)指南的依从性。
该研究纳入了来自亚洲 5 个国家 113 个中心的 2969 名患者。最常见的 VTE 风险因素包括年龄>60 岁(57.1%)、长时间卧床(50.6%)、呼吸系统疾病(41.3%)和急性传染病(36.2%)。医生评估的“极高”VTE 风险(8.4%)与 Caprini“极高”风险分层(54.9%)之间存在很大差距。2919 名(98.3%)患者接受了预防治疗(22.9%-仅采用机械预防,31.2%-仅采用药物预防,44.2%-同时采用机械和药物预防,1.7%-未进行预防)。早期活动(44.3%)和 LMWH(66.2%,预防治疗的平均持续时间为 8.6 天)分别是最常见的机械和药物预防措施。根据 ACCP 指南(4.7%根据日本指南),80.6%的患者接受了血栓预防治疗。
在所参与的亚洲国家,内科 ICU 患者对 VTE 风险的评估存在严重低估,且对血栓预防的指南遵循度较低。这强调了需要提高对最佳 VTE 风险评估的认识,并在高危内科 ICU 患者中更好地实施适当的血栓预防。